Prof. Dr. Renata Stripecke - Curriculum Vitae
Education and Professional Career
1988-1990: Konrad-Adenauer Stiftung Fellow at the Institute for Genetics and Microbiology Ludwig-Maximilians-University (Munich, Germany).
1990-1993: “Doktor der Naturwissenschaften” (Dr. rer. nat./ PhD) in Molecular Biology at the European Molecular Biology Laboratory and University Heidelberg, Germany.
1994-1995: Post-doc Howard Hughes Medical Institute, University of California, Los Angeles (Los Angeles, CA, USA).
1995-1999: Research Fellow at Children’s Hospital Los Angeles, University of Southern California (Los Angeles, CA, USA).
1999-2003: Assistant Professor of Research Dept. Pathology, School of Medicine, University of Southern California, Los Angeles, CA, USA.
2000-2002: “Habilitation” (hab.) in Genetics and Molecular Biology at the University of Hamburg (Hamburg, Germany).
2003-2007: Adjunct Assistant Professor and Co-director UCLA Molecular Vector Core, Dept. Medicine/ School of Medicine, University of California (UCLA), Los Angeles, CA, USA.
2007-2008: Lecturer (Privat Dozentin) and Principal Investigator Excellence Cluster REBIRTH, Hannover Medical School (MHH), Hannover.
2008-2022: Professor (W2) at the Dept. Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover, Germany.
2008-2022: Faculty Member of the MHH Hannover Biomedical Research School in the structured PhD programs “Molecular Medicine”,” Regenerative Sciences”, “Infectious Biology” and MD program “Strucmed”.
2015: Sabbatical in Cell and Gene Therapies at the Baylor College of Medicine (Houston, USA).
since 2022: Professor (W3) “Chair of Institute Translational Immuno-Oncology”, at the University Hospital Cologne.
since 2023: Associate Member of the PhD Committee of the Interdisciplinary Program Molecular Medicine (IPMM) and Center of Molecular Medicine Cologne (CMMC). 1983-1988: Bachellor’s and Master’s Degree and in Biological Sciences / Genetics, UNICAMP - State University of Campinas (Campinas, SP, Brazil).
Awards, Distinctions and Scientific Activities
2023-2026: Member Committee Cancer and Cell and Gene Therapy American Society of Gene and Cell Therapy
2019-2025: Member Educational Committee American Society of Gene and Cell Therapy
2017-2018: Chair International Committee American Society of Gene and Cell Therapy
2016-2017: Member International Committee American Society of Gene and Cell Therapy
2015-2016: Committee Member “Immune responses to Gene and Cell Therapy” American Society of Gene and Cell Therapy
2015: Sabbatical in Houston funded by the German Research Council (DFG Germany).
2015: Hannoverimpuls Ideenpreis for a Startup in the Region Hannover
since 2010: Member of Cancer Immune Therapy (CIMT, Germany)
2008-2019: Sondersforschungsbereich (SFB) 738, Hannover Medical School, Principal Investigator
since 2007: Member of European Society for Cell and Gene Therapy (ESCGT, Europe).
2007-2019: Excellence Cluster Rebirth, Hannover Medical School, Principal Investigator
2001-2002: Habilitation Scholarship funded by the German Research Council (DFG Germany).
2000-2003: National Cancer Institute/NIH K01/ Howard Temin Award (USA).
1999-2002: Leukemia and Lymphoma Society Special Fellow Award (USA).
since 1997: Member of American Society of Gene and Cell Therapy (ASGCT, USA).
1997-1998: Children’s Hospital Los Angeles Career Award (USA)
1994-1995: Postdoc scholarship funded by the German Research Council (DFG Germany).
Reviewer for Funding Agencies (selected)
German Research Council (DFG) Germany; Deutsche Jose Carreras Leukämie Stiftung, Germany; The Concern Foundation Los Angeles, CA, USA; Deutsche Krebshilfe Germany; Fonds Wetenschappelijk Onderzoek (FWO), Belgium; Landsteiner Foundation for Blood Transfusion Research, Netherlands; Fundacao a Ciencia e Tecnologia, Portugal; Fund for Scientific Research, Belgium; Life Sciences and Health, Translational Adult Stem Cell Research, Netherlands; Deutscher Akademischer Austauschdienst (DAAD), Germany.
Associate Editor
Frontiers in Immunology (Cancer Immunology and Immunotherapy)
Cancer Gene Therapy
Human Gene Therapy